← Evidence map

ArticleFrontiers in neurology2024

Cost-effectiveness analysis of rimegepant for on-demand acute treatment of migraine in China.

Shuo Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39246609